Navigation Links
Intrexon Organizes Around New Synthetic Biology Markets
Date:5/9/2013

GERMANTOWN, Md., May 9, 2013 /PRNewswire/ -- Intrexon Corporation, a leader in synthetic biology that is helping companies design and develop products incorporating its Better DNA™, today announced it has aligned its industry markets to focus on four key sectors: Health, Food, Energy and Environment.

Intrexon currently has nine collaborations in Health and Food to create products embodying engineered bio-based solutions.  The goal of the new market alignment is to accelerate business development across all of Intrexon's key market sectors using the company's Exclusive Channel Collaboration (ECC) model.

Since Intrexon's founding in 1998 the company has developed its core technology, the UltraVector® platform, to accelerate development of genetically-enhanced products at industrial scale.  Using a dynamic library of more than two million diverse, modular genetic components, UltraVector enables the discovery, design, assembly and testing of a wide spectrum of multigenic biological systems.As part of its new market strategy, Intrexon named the following executives with deep industry experience to lead each market sector:

  • Health will be led by Dr. Samuel Broder , Executive Director of the Intrexon Institute for Biomolecular Research and former Director of the National Cancer Institute.
  • Food will be led by Dr. Thomas Kasser , with more than twenty-five years of senior management experience in agricultural biotechnology and animal health and nutrition, recognized as a Monsanto Fellow for his scientific and technical excellence.
  • Energy will be led by Robert Walsh , with over 30 years of global petroleum and chemical industry experience, including 26 years at Royal Dutch Shell.
  • Environment will be led by Nick Macris , with 15 years in the specialty chemic
    '/>"/>

  • SOURCE Intrexon Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
    2. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
    3. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
    4. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
    5. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
    6. Physicists in Mainz and all around the world cheer the discovery of the Higgs particle
    7. BioInformatics LLC New Product Launch – RateMyProduct, a Quick Turnaround Product Assessment Tool for Life Science Suppliers
    8. Reliable electric power supply for the energy turn-around
    9. "Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals
    10. Synthetic Biology: Emerging Global Markets
    11. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... 2015  Traverse Biosciences announced today that it ... agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ: ... for the treatment and control of periodontal disease ... Biosciences has also granted Aratana an exclusive option ... of periodontal disease in companion animals, inclusive of ...
    (Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - The ... partners are pleased to announce the formation of ... on developing treatments for cancer that harness the ... represents a unique collaboration between the Children,s Hospital ... Research Institute, McMaster University, the Ontario Institute for ...
    (Date:5/4/2015)... May 04, 2015 Genedata, a ... discovery and life science research, today announced the ... latest version of its enterprise solution for biologics ... enables more efficient discovery and development of novel ... integrate and address protein optimization and developability requirements. ...
    (Date:5/4/2015)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... medical needs in the areas of inflammation, oncology and ... data from three of its biodefense programs at the ... on May 12-14, 2015 to be held at the ... St. Louis MO 63101. ...
    Breaking Biology Technology:Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12
    ... 7 Endocare, Inc. (Nasdaq: ENDO ) ... have entered into a settlement agreement stipulating to termination ... Galil Medical pursuant to which Endocare would have acquired ... in Delaware Chancery Court. , , ...
    ... Covance Inc. today ... company as vice president and chief scientific officer of ... industry experience, including bioanalytical research, translational research, and talent ... development strategy for Covance,s bioanalytical services. , ...
    ... advanced energy research , , MONTREAL, July 7 ... technology company, today announced that it will jointly form ... Edmonton and the Alberta Energy Research Institute (AERI). , ... demonstration of novel catalytic conversion processes to produce advanced ...
    Cached Biology Technology:Endocare and Galil Medical Announce Settlement of Litigation 2Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services 2Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada 2Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada 3
    (Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
    (Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
    (Date:4/10/2015)... 10, 2015 Research and Markets ... "Security Competitive Profiles - NEC" report to ... NEC will continue to supply a range of ... with a company focus on the development of a ... Winning opportunities in the Asia-Pacific ...
    Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
    ... Researchers at the Georgia Institute of Technology and the ... goal of automating the management of sedation in hospital intensive ... clinical data to accurately determine a patient,s level of sedation ... in the level. "ICU nurses have one of the ...
    ... more humanity acidifies and warms the world,s oceans with carbon ... our coral reefs. That,s the blunt message from a ... that ocean acidification and global warming will combine with local ... coral reefs right when they are struggling to survive. ...
    ... most common cardiac arrhythmia (abnormal heart rhythm). Its name ... muscles of the atria, instead of a coordinated contraction. ... in episodes lasting from minutes to weeks, or it ... alone is not in itself generally life-threatening, but it ...
    Cached Biology News:Researchers working toward automating sedation in intensive care units 2Researchers working toward automating sedation in intensive care units 3Researchers working toward automating sedation in intensive care units 4Acid oceans demand greater reef care 2Moderate-to-heavy alcohol intake may increase risk of atrial fibrillation 2
    ...
    ...
    ... StdSens reagents and supplies, for 10 ... sufficient to perform standard-sensitivity RNA analysis ... the Experion automated electrophoresis system. Supplied ... microliters RNA StdSens stain, 20 microliters ...
    ... designed for enhanced translation of cloned sequences in ... lysate. The maps for pCITE-2b(+) and pCITE-2c(+) are ... pCITE-2b(+) is a 3793 bp plasmid; it lacks ... I sites. Subtract 7 bp from all sites ...
    Biology Products: